Mirum Pharmaceuticals, Inc.

MIRM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$104.33-0.25%

2026-08-04

Financials

Valuation Metrics

Mirum Pharmaceuticals, Inc.'s Market Cap is $6.36B. At end of 2025 it was $3.97B. Ranked #1213 of 3,112 in US market (top 39%), #397 of 1,445 on NASDAQ (top 27%), #66 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 25%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	$6.36B	US#1,213/3,112 Sec#66/269
Revenue	$570M	US#2,284/3,112 Sec#75/269
Net Income	$-799M	US—/3,112 Sec—/269
Total Assets	$891M	US#2,495/3,112 Sec#105/269
Net Assets	$242M	US#2,651/3,112 Sec#178/269
Value
P/B	26.24x	US#2,863/3,112 Sec#242/269
P/S	11.17x	US#2,695/3,112 Sec#125/269
FCF Yield	-2.71%	US—/3,112 Sec—/269
Profitability
ROA	-89.67%	US#3,040/3,112 Sec#261/269
Op. Margin	-12.31%	US#2,654/3,112 Sec#103/269
Revenue Growth	43.28%	US#345/3,112 Sec#57/269
Financial Health
Debt Ratio	267.40%	US#2,030/3,112 Sec#214/269
Total Debt	$324M	US#2,009/3,112 Sec#73/269
FCF	$-173M	US#2,703/3,112 Sec#202/269
Cash	$325M	US#1,369/3,112 Sec#74/269
Current Ratio	2.09x	US#1,204/3,112 Sec#224/269
Performance
1Y Return	99.71%	US#311/3,112 Sec#81/269
1M Return	-16.93%	US#2,876/3,112 Sec#218/269
From 52W High	-19.75%	US#1,698/3,112 Sec#107/269
1Y MDD	-20.55%	US#724/3,112 Sec#30/269
Trading
Volume	550,665 shares	US#2,093/3,112 Sec#204/269
Trading Value	$58M	US#1,334/3,112 Sec#81/269
Per Share
EPS	$-0.47	US—/3,112 Sec—/269
BPS	$6.27	US#2,100/3,112 Sec#108/269